Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations?
- 8 February 2011
- journal article
- case report
- Published by Hindawi Limited in Human Mutation
- Vol. 32 (4) , 467-475
Abstract
We report on two unprecedented cases of pseudoexon (PE) activation in the DMD gene resulting from pure intronic double‐deletion events that possibly involve microhomology‐mediated mechanisms. Array comparative genomic hybridization analysis and direct genomic sequencing allowed us to elucidate the causes of the pathological PE inclusion detected in the RNA of the patients. In the first case (Duchenne phenotype), we showed that the inserted 387‐bp PE was originated from an inverted ∼57 kb genomic region of intron 44 flanked by two deleted ∼52 kb and ∼1 kb segments. In the second case (Becker phenotype), we identified in intron 56 two small deletions of 592 bp (del 1) and 29 bp (del 2) directly flanking a 166‐bp PE located in very close proximity (134 bp) to exon 57. The key role of del 1 in PE activation was established by using splicing reporter minigenes. However, the analysis of mutant constructs failed to identify cis elements that regulate the inclusion of the PE and suggested that other splicing regulatory factors may be involved such as RNA structure. Our study introduces a new class of mutations in the DMD gene and emphasizes the potential role of underdetected intronic rearrangements in human diseases. Hum Mutat 32:1–9, 2011.Keywords
Funding Information
- Association Française contre les Myopathies; Postdoctoral fellowship from AFM (14178)
- a fellowship from the Algerian Ministry of Education and Scientific Research
This publication has 43 references indexed in Scilit:
- Genomic rearrangements in inherited disease and cancerSeminars in Cancer Biology, 2010
- Model-based detection of alternative splicing signalsBioinformatics, 2010
- A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathiesBMC Genomics, 2008
- RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion eventsNucleic Acids Research, 2007
- Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD geneHuman Mutation, 2006
- Defective splicing, disease and therapy: searching for master checkpoints in exon definitionNucleic Acids Research, 2006
- Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohortAmerican Journal of Medical Genetics Part A, 2005
- An intragenic deletion/inversion event in the DMD gene determines a novel exon creation and results in a BMD phenotypeHuman Genetics, 2004
- Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.Proceedings of the National Academy of Sciences, 1991
- Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNANucleic Acids Research, 1984